SG11201809177UA - Composition for use in the prophylaxis of allergic disease - Google Patents
Composition for use in the prophylaxis of allergic diseaseInfo
- Publication number
- SG11201809177UA SG11201809177UA SG11201809177UA SG11201809177UA SG11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- rule
- dgla
- applicant
- prophylaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 07 December 2017 (07.12.2017) WIP0 I PCT omit Oil DID Immo oimIE (10) International Publication Number WO 2017/207124 Al (51) International Patent Classification: A61K 31/202 (2006.01) A61P 27/14 (2006.01) (21) International Application Number: Published: — with international search report (Art. 21(3)) PCT/EP2017/055680 (22) International Filing Date: 10 March 2017 (10.03.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 16172431.5 01 June 2016 (01.06.2016) EP (71) Applicant: NESTEC S.A. [CH/CH]; Avenue Nestle 55, 1800 VEVEY (CH). (72) Inventors: ECKHARDT, Erik; 34, rue Ernest Zegut, 01170 Gex (FR). NEMBRINI, Chiara; 34, Route de Palezieux, 1610 ORON-LA-VILLE (CH). JOURDAIN, Laureline; 1717 North Verdugo Road, Apt 284, CA, Glen- dale, California 91208 (US). (74) Agent: NAUDE, Dawn; Nestle Research Center, Vers- chez-les-Blanc, 1000 Lausanne 26 (CH). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: 1-1 as to applicant's entitlement to apply for and be granted a • patent (Rule 4.170) as to the applicant's entitlement to claim the priority of the 71' • earlier application (Rule 4.17(iii)) 11 of inventorship (Rule 4.17(iv)) O N (54) Title: COMPOSITION FOR USE IN THE PROPHYLAXIS OF ALLERGIC DISEASE 0 (57) : Dihomo-gamma-linolenic acid (DGLA) or a composition comprising DGLA for use in the prophylaxis of allergic disease \" in the offspring of mammalian subject wherein said DGLA is administered to said subject pre-pregnancy and/or during pregnancy and/ 0 or during lactation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16172431 | 2016-06-01 | ||
PCT/EP2017/055680 WO2017207124A1 (en) | 2016-06-01 | 2017-03-10 | Composition for use in the prophylaxis of allergic disease |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201809177UA true SG11201809177UA (en) | 2018-12-28 |
Family
ID=56108531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201809177UA SG11201809177UA (en) | 2016-06-01 | 2017-03-10 | Composition for use in the prophylaxis of allergic disease |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP3463332B1 (en) |
CN (1) | CN109152759A (en) |
AR (1) | AR107869A1 (en) |
BR (1) | BR112018073060A2 (en) |
CA (1) | CA3024191A1 (en) |
ES (1) | ES2877810T3 (en) |
MX (1) | MX2018014140A (en) |
PH (1) | PH12018502252A1 (en) |
PT (1) | PT3463332T (en) |
SG (1) | SG11201809177UA (en) |
TW (1) | TWI803459B (en) |
WO (1) | WO2017207124A1 (en) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
GB9217780D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
GB9217781D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
CA2119000A1 (en) * | 1993-03-19 | 1994-09-20 | David Frederick Horrobin | Formulation for use in smokers |
EP0711503A3 (en) * | 1994-11-14 | 1997-11-26 | Scotia Holdings Plc | Milk fortified with GLA and/or DGLA |
GB9510636D0 (en) * | 1995-05-25 | 1995-07-19 | Scotia Holdings Plc | Fatty acid treatment |
US20040076695A1 (en) * | 2002-07-08 | 2004-04-22 | Advanced Vision Research | EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
JP5546087B2 (en) * | 2005-02-14 | 2014-07-09 | サントリーホールディングス株式会社 | Oral treatment or prevention agent for skin diseases |
-
2017
- 2017-03-10 WO PCT/EP2017/055680 patent/WO2017207124A1/en unknown
- 2017-03-10 EP EP17711109.3A patent/EP3463332B1/en active Active
- 2017-03-10 PT PT177111093T patent/PT3463332T/en unknown
- 2017-03-10 BR BR112018073060-2A patent/BR112018073060A2/en not_active Application Discontinuation
- 2017-03-10 CA CA3024191A patent/CA3024191A1/en active Pending
- 2017-03-10 SG SG11201809177UA patent/SG11201809177UA/en unknown
- 2017-03-10 MX MX2018014140A patent/MX2018014140A/en unknown
- 2017-03-10 ES ES17711109T patent/ES2877810T3/en active Active
- 2017-03-10 CN CN201780031490.3A patent/CN109152759A/en active Pending
- 2017-03-13 TW TW106108163A patent/TWI803459B/en active
- 2017-03-13 AR ARP170100624A patent/AR107869A1/en unknown
-
2018
- 2018-10-22 PH PH12018502252A patent/PH12018502252A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3463332B1 (en) | 2021-04-21 |
AR107869A1 (en) | 2018-06-13 |
MX2018014140A (en) | 2019-02-25 |
ES2877810T3 (en) | 2021-11-17 |
CA3024191A1 (en) | 2017-12-07 |
TWI803459B (en) | 2023-06-01 |
PT3463332T (en) | 2021-06-30 |
WO2017207124A1 (en) | 2017-12-07 |
CN109152759A (en) | 2019-01-04 |
BR112018073060A2 (en) | 2019-04-09 |
TW201742624A (en) | 2017-12-16 |
EP3463332A1 (en) | 2019-04-10 |
PH12018502252A1 (en) | 2019-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201909963YA (en) | Methods for treating dravet syndrome | |
SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
SG11201909960UA (en) | Methods for improving memory and cognition and for treating memory and cognitive disorders | |
SG11201909022PA (en) | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | |
SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
SG11201907032RA (en) | Amino pyrimidine compounds useful as ssao inhibitors | |
SG11201810420YA (en) | Antibodies to alpha-synuclein and uses thereof | |
SG11201407837WA (en) | Beta-hairpin peptidomimetics | |
SG11201810371XA (en) | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | |
SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
SG11201907356SA (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
SG11201901558VA (en) | Pth compounds with low peak-to-trough ratios | |
SG11201805001UA (en) | Method of treating influenza a | |
SG11201402986RA (en) | Kinase inhibitors | |
SG11201807597UA (en) | Methods of treating depression using orexin-2 receptor antagonists | |
SG11201807255YA (en) | Treatment of autoimmune diseases with combinations of rxr agonists and thyroid hormones | |
SG11201901673SA (en) | Imidazole derivatives and their use in the treatment of autoimmune or inflammatory diseases or cancers | |
SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
SG11201804587QA (en) | Isoindole compounds | |
SG11201806424TA (en) | Therapeutic compounds | |
SG11201408171SA (en) | Fbxo3 inhibitors | |
SG11201908065YA (en) | Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
SG11201806127XA (en) | Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate | |
SG11201810801QA (en) | Brain delivery protein | |
SG11201901689YA (en) | Compounds for treating diseases associated with a mitochondrial dysfonction |